David C. Sachs Immunity Bio, Inc. (IBRX) insider trading activity

David C. Sachs is Chief Financial Officer of ImmunityBio, Inc.. Currently has a direct ownership of 185,838 shares of IBRX, which is worth approximately $981,224. The most recent transaction as insider was on Jan 31, 2024, when has been sold 26,835 shares (Common Stock) at a price of $3.36 per share, resulting in proceeds of $90,165. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 186K

0% 3M change

52.27% 12M change

Total Value Held $981,224

David C. Sachs Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 31 2024	SELL Payment of exercise price or tax liability	$90,165 $3.36 p/Share	26,835 Reduced 12.62%	185,838 Common Stock
Jan 31 2024	BUY Exercise of conversion of derivative security	-	70,745 Added 24.96%	212,673 Common Stock
Dec 31 2023	SELL Payment of exercise price or tax liability	$52,765 $5.02 p/Share	10,511 Reduced 6.9%	141,928 Common Stock
Dec 31 2023	BUY Exercise of conversion of derivative security	-	30,397 Added 16.63%	152,439 Common Stock
Sep 01 2023	BUY Exercise of conversion of derivative security	-	70,744 Added 36.7%	122,042 Common Stock
Dec 31 2022	BUY Exercise of conversion of derivative security	-	7,598 Added 12.9%	51,298 Common Stock
Dec 09 2021	BUY Exercise of conversion of derivative security	-	17,242 Added 28.29%	43,700 Common Stock
Sep 09 2021	BUY Exercise of conversion of derivative security	-	7,598 Added 22.31%	26,458 Common Stock

DCS

David C. Sachs

Chief Financial Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Value

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to ImmunityBio, Inc.

Track Activities on IBRX

Account